NeoGenomics Laboratories · 3 weeks ago
Temporary, Accounts Payable Processor
United States
Full-time
Remote
Entry Level
1+ years expNeoGenomics Laboratories is a company dedicated to improving patient care through exceptional work in the cancer reference laboratory field. They are seeking a Temporary Accounts Payable Processor to provide administrative support to the Finance Department, focusing on processing vendor invoices and maintaining supplier records.
BiotechnologyGeneticsHealth CareHealth DiagnosticsMedicalPharmaceutical
Responsibilities
Manages AP email inbox and Oracle Fusion OCR queue for invoices and vendor inquiries
Record invoices into the Company’s ERP system (Oracle Fusion); sort, code, and match invoices (2-way and 3-way match)
Ensure proper approval and support for non-PO invoices are obtained
Identify, research and resolve invoice discrepancies/issues that may arise
Prepares invoices for payment in accordance with terms negotiated after discount has been calculated and/or late fees and credits have been resolved
Prepares checks for delivery
Maintain and update supplier/vendor records
Provide timely responses to internal and external customer inquiries
Ensure that established financial controls are adhered to in the performance of specified responsibilities
Assist with providing supporting documentation for audits
Assist in ad-hoc requests by management
Qualification
Required
1+ years of accounts payable experience
Ability to process ERP generated data for reporting and analysis
Proficiency Microsoft Office, including Excel, Outlook, Word, and PowerPoint
Strong customer service orientation
Team-oriented
Strong communication skills, both oral and written
Works productively and efficiently to achieve company and departmental goals
Preferred
Associates Degree, Business Administration preferred
Company
NeoGenomics Laboratories
NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and oncology data solutions.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$925.9M2021-05-05Post Ipo Equity· $200M
2020-04-30Post Ipo Equity· $125.4M
2020-04-30Post Ipo Debt· $175M
Leadership Team
Ravi Ada
Chief Technology Officer, Informatics Division
George A. Cardoza
Chief Financial Officer
Recent News
2026-01-04
Company data provided by crunchbase